635 results District Court ruled on the recognition of the res judicata effect of a Turkish judgment and dismissed an antitrust follow on damages claim regarding the cathode-ray tube markets The District Court of Oost-Brabant recognized the res judicata effect of a Turkish court of appeal judgment, in which the Turkish court had dismissed antitrust damages claims brought by Vestel against Philips, Samsung, LGE, Technicolor, TTD and TDP. Verticale prijsbinding: handhaving, boetes en schadeclaims We bespreken de wijze waarop bedrijven hun afnemers ongeoorloofd dwingen tot het rekenen van minimumprijzen en waarom dat niet mag. De ACM handhaaft streng en leveranciers kunnen rekenen op hoge boetes en schadeclaims van gedupeerde consumenten. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. FDI screening guidance: shedding some light in the darkness The Dutch general investment screening regime came into effect in June 2023. Decisions are not yet publicly available. However, three guidance papers list the practical experience gained so far and help to assess whether a transaction is notifiable. AFM's spotlight on substantial holding notifications In its latest market watch, the AFM places a spotlight on notifications of substantial holdings and gross short positions in response to the ongoing public discourse on the issue. Settlement procedure and fine for vertical price fixing in Belgium The Belgian Competition Authority imposed a fine of €490,112 on Le Creuset for vertical price fixing (also known as resale price maintenance). On repeat but louder: the ACM’s 2024 priorities On 23 January 2024, the ACM announced its priorities for 2024. The energy transition, the digital economy and sustainability are still on the ACM’s priority list, but now with better-equipped enforcement methods available. Stibbe Amsterdam appoints two new partners We are pleased to announce that Stibbe Amsterdam has promoted Marc Habermehl and Stijn de Jong to the position of partner effective 1 January 2024. These appointments further strengthen our Corporate/M&A and EU & Competition Law practices. Preventing environmental damage through sustainable cooperation Following the EC’s Horizontal Guidelines, the ACM and CMA have also published updated guidance on sustainability agreements. The approaches adopted by the three authorities are largely similar, but leave room for divergent assessments in some respects. Dutch court confirms: Samsung's 'price recommendations' practices were unlawful The Rotterdam District Court has delivered its judgment in the ACM's first-ever vertical restraints case. It upholds the fine imposed on Samsung for coordinating its retailers' online consumer prices under the pretence of 'price recommendations'. Kroniek. Bestuurs- en civielrechtelijke rechtspraak mededingingsrecht 2022 In deze kroniek geven we een overzicht van de meest spraakmakende rechtspraak binnen het mededingingsrecht in 2022. Elisabeth Gabizon Junior Associate Brussels Bettine Wils Junior Associate Amsterdam Jelmer Richel Junior Associate Amsterdam Developments in green bonds: On 21 December 2024 the EU Green Bond Regulation starts to apply In this blog, Marieke Driessen and Niek Groenendijk of our Financial Markets team discuss the EU green bonds regulation which will start applying in 2024. Wetgevingsbrieven 2023 van de AFM en DNB Ingrid van der Klooster bespreekt de wetgevingswensen van de toezichthouders AFM en DNB en de reactie daarop van de betreffende ministers. Die wensen betreffen dit jaar een aantal ingrijpende wijzigingen in financiële toezichtwetgeving. Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Pagination Previous page Page 2 Current page 3 Page 4 Page 5 Next page
District Court ruled on the recognition of the res judicata effect of a Turkish judgment and dismissed an antitrust follow on damages claim regarding the cathode-ray tube markets The District Court of Oost-Brabant recognized the res judicata effect of a Turkish court of appeal judgment, in which the Turkish court had dismissed antitrust damages claims brought by Vestel against Philips, Samsung, LGE, Technicolor, TTD and TDP.
Verticale prijsbinding: handhaving, boetes en schadeclaims We bespreken de wijze waarop bedrijven hun afnemers ongeoorloofd dwingen tot het rekenen van minimumprijzen en waarom dat niet mag. De ACM handhaaft streng en leveranciers kunnen rekenen op hoge boetes en schadeclaims van gedupeerde consumenten.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
FDI screening guidance: shedding some light in the darkness The Dutch general investment screening regime came into effect in June 2023. Decisions are not yet publicly available. However, three guidance papers list the practical experience gained so far and help to assess whether a transaction is notifiable.
AFM's spotlight on substantial holding notifications In its latest market watch, the AFM places a spotlight on notifications of substantial holdings and gross short positions in response to the ongoing public discourse on the issue.
Settlement procedure and fine for vertical price fixing in Belgium The Belgian Competition Authority imposed a fine of €490,112 on Le Creuset for vertical price fixing (also known as resale price maintenance).
On repeat but louder: the ACM’s 2024 priorities On 23 January 2024, the ACM announced its priorities for 2024. The energy transition, the digital economy and sustainability are still on the ACM’s priority list, but now with better-equipped enforcement methods available.
Stibbe Amsterdam appoints two new partners We are pleased to announce that Stibbe Amsterdam has promoted Marc Habermehl and Stijn de Jong to the position of partner effective 1 January 2024. These appointments further strengthen our Corporate/M&A and EU & Competition Law practices.
Preventing environmental damage through sustainable cooperation Following the EC’s Horizontal Guidelines, the ACM and CMA have also published updated guidance on sustainability agreements. The approaches adopted by the three authorities are largely similar, but leave room for divergent assessments in some respects.
Dutch court confirms: Samsung's 'price recommendations' practices were unlawful The Rotterdam District Court has delivered its judgment in the ACM's first-ever vertical restraints case. It upholds the fine imposed on Samsung for coordinating its retailers' online consumer prices under the pretence of 'price recommendations'.
Kroniek. Bestuurs- en civielrechtelijke rechtspraak mededingingsrecht 2022 In deze kroniek geven we een overzicht van de meest spraakmakende rechtspraak binnen het mededingingsrecht in 2022.
Developments in green bonds: On 21 December 2024 the EU Green Bond Regulation starts to apply In this blog, Marieke Driessen and Niek Groenendijk of our Financial Markets team discuss the EU green bonds regulation which will start applying in 2024.
Wetgevingsbrieven 2023 van de AFM en DNB Ingrid van der Klooster bespreekt de wetgevingswensen van de toezichthouders AFM en DNB en de reactie daarop van de betreffende ministers. Die wensen betreffen dit jaar een aantal ingrijpende wijzigingen in financiële toezichtwetgeving.
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.